Form 4: Revolution Medicines COO Margaret Horn Sells Shares to Cover Tax Obligations

Margaret Horn, Chief Operating Officer of Revolution Medicines, sold 4,331 shares of common stock on September 16, 2024, to cover tax obligations related to vesting restricted stock units.

Summary

• Margaret Horn, the Chief Operating Officer of Revolution Medicines, sold 4,331 shares of the company's common stock on September 16, 2024.
• The sale was executed at a price of $44.1853 per share.
• This transaction was made pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2023, to cover tax withholding obligations upon the vesting of restricted stock units (RSUs).
• Following the transaction, Horn directly owns 132,320 shares of Revolution Medicines, including 77,300 RSUs.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider stock sale for tax purposes. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It is common for executives to sell shares to cover tax obligations related to vesting equity awards. The Rule 10b5-1 plan allows insiders to trade without being accused of acting on non-public information.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the disclosure that it was for tax obligations under a pre-arranged plan mitigates this concern.

Key Dates